Clinical Trial

Efficacy and Safety of Minocycline in Acute Spontaneous Intracerebral Hemorrhage

Study acronym: MISTICH
Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
This is a prospective, multicenter, randomized, double-blind, placebo-controlled clinical trial. It aims to evaluate the efficacy and safety of oral minocycline in patients with acute spontaneous intracerebral hemorrhage within 48 hours of onset.
Protocol Amendment History 2 changes
critical Recruitment opened 2026-04-24
notable Trial sites expanded: 1 -> 41 locations 2026-04-24
Trial Details
NCT Number NCT07338175
Lead Sponsor Beijing Tiantan Hospital
Conditions Intracerebral Hemorrhage
Enrollment 1,192 participants
Start Date 2026-04-02
Primary Completion 2028-06 (estimated)
Study Completion 2028-12 (estimated)
Updated on ClinicalTrials.gov 2026-04-23